1. Academic Validation
  2. Identification of 5-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)thiophene-2-Carboxamides as Novel and Selective Monoamine Oxidase B Inhibitors Used to Improve Memory and Cognition

Identification of 5-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)thiophene-2-Carboxamides as Novel and Selective Monoamine Oxidase B Inhibitors Used to Improve Memory and Cognition

  • ACS Chem Neurosci. 2017 Dec 20;8(12):2746-2758. doi: 10.1021/acschemneuro.7b00282.
Alan P Kaplan 1 Terence Keenan 1 Roderick Scott 1 Xianbo Zhou 2 Rusiko Bourchouladze 1 Andrew J McRiner 3 Mark E Wilson 1 Darlene Romashko 4 Regina Miller 5 Matthew Bletsch 6 Gary Anderson 1 Jennifer Stanley 1 Adia Zhang 1 Dong Lee 1 John Nikpur 1
Affiliations

Affiliations

  • 1 Dart NeuroScience, LLC , 12278 Scripps Summit Drive, San Diego, California 92131, United States.
  • 2 SJN Biomed LTD , 398 West Second Ring Road, Kunming 650118, China.
  • 3 X-Chem Pharmaceuticals, Inc. , 100 Beaver Street, Suite 101, Waltham, Massachusetts 02453, United States.
  • 4 Aset Therapeutics , 25 Health Sciences Drive, Stony Brook, New York 11790, United States.
  • 5 Bristol-Myers Squibb , 5 Research Parkway, Wallingford, Connecticut 06492, United States.
  • 6 The Hain Celestial Group , 1111 Marcus Avenue, New Hyde Park, New York 11042, United States.
Abstract

Initial work in Drosophila and mice demonstrated that the transcription factor cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) is a master control gene for memory formation. The relationship between CREB and memory has also been found to be true in Other species, including aplysia and rats. It is thus well-established that CREB activation plays a central role in memory enhancement and that CREB is activated during memory formation. On the basis of these findings, a phenotypic high-throughput screening campaign utilizing a CRE-luciferase (CRE-Luci) SK-N-MC cell line was performed to identify compounds that enhance transcriptional activation of the CRE promoter with a suboptimal dose of forskolin. A number of small-molecule hits of unknown mechanisms of action were identified in the screening campaign, including HT-0411. Follow-up studies suggested that the CREB activation by HT-0411 is attributed to its specific and selective inhibition of Monoamine Oxidase B (MAO-B). Further, HT-0411 was shown to improve 24 h memory in rodents in a contextual fear conditioning model. This report describes the lead optimization of a series of 5-(1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl) thiophene-2-carboxamides that were identified as novel, potent, and selective inhibitors of MAO-B. Extensive SAR studies and in vivo behavioral evaluations of this and Other related analogue series identified a number of potential clinical development candidates; ultimately, compound 8f was identified as a candidate molecule with high selectivity toward MAO-B (29-56 nM) over MAO-A (19% inhibition at a screening concentration of 50 μM), an excellent profile against a panel of other Enzymes and receptors, good pharmacokinetic properties in rodents and dogs, and efficacy in multiple rodent memory models.

Keywords

CREB activation; MAO-B inhibitors; long-term memory; phenotypic screening; synaptic plasticity.

Figures
Products